Financial Gravity Asset Management, Inc. Intercept Pharmaceuticals, Inc. Transaction History

Financial Gravity Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 28, 2020	SELL	$57.36 - $124.1 $17,494 - $37,850	-305 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$58.69 - $80.46 $58 - $80	1 Added 0.33%	305 $20,000
Q2 2019 Jul 26, 2019	BUY	$77.77 - $120.68 $311 - $482	4 Added 1.33%	304 $24,000
Q1 2019 Apr 19, 2019	BUY	$91.83 - $120.68 $27,549 - $36,204	300 New	300 $33,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.